![Man in the lab Man working in the lab](/sites/default/files/2024-05/PR_OSE.jpg)
May 22, 2024
Partnership for first-in-class cancer and CRM treatments
![doctor pointing on spine](/sites/default/files/2024-02/CBmed.jpg)
February 08, 2024
Boehringer Ingelheim and CBmed join forces to translate novel cancer therapy approaches faster into new medicines for patients
![Boehringer Ingelheim and ZEISS join forces to early detect eye diseases and prevent vision loss](/sites/default/files/2023-11/BI_Workplace_Lab_Discussion-01_RGB_001%20%281%29.jpg)
November 22, 2023
Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma
![monecules](/sites/default/files/2023-01/Teaser_3t.jpg)
January 09, 2023
New cancer therapeutics collaboration with 3T Bio
![A*Star](/sites/default/files/2022-06/thumbnail.jpg)
June 02, 2022
A*STAR antibodies bolster ADC and T-Cell engager development
![Acquisition expands research in cancer immunology Acquisition expands research in cancer immunology](/sites/default/files/2023-03/shutterstock_274014893_0.jpg)
September 21, 2021
Acquisition to advance cancer immunology research
![clinical-collaboration-with-Amgen clinical-collaboration-with-Amgen](/sites/default/files/2023-03/WebsiteCard.jpg)
September 16, 2021
Clinical collaboration with Amgen on KRAS
![expanded-collaboration-MD-Anderson expanded-collaboration-MD-Anderson](/sites/default/files/2023-03/MDACC_WebsiteCard.jpg)
April 14, 2021
Expansion of Collaboration with MD Anderson to Explore KRAS and TRAILR2 Compounds in Lung Cancer
![Strategic-collaboration-with-EnaraBio Strategic-collaboration-with-EnaraBio](/sites/default/files/2023-03/thumbnail%20%281%29.jpg)
January 12, 2021
Collaboration with Enara Bio on Cancer Immunotherapies
![Agreement-to-acquire-NBE-Therapeutics Agreement-to-acquire-NBE-Therapeutics](/sites/default/files/2023-03/thumbnail_1.jpg)
December 10, 2020
Boehringer Ingelheim to acquire NBE-Therapeutics
![Agreement-to-acquire-Labor-Dr.-Merk Agreement-to-acquire-Labor-Dr.-Merk](/sites/default/files/2023-03/LINDEN_Website_Card.jpg)
December 09, 2020
Boehringer Ingelheim to acquire Labor Dr. Merk and Kollegen
![collaboration-proxygen-molecular-glue-degraders collaboration-proxygen-molecular-glue-degraders](/sites/default/files/2023-03/Proxygen_Website.jpg)
December 07, 2020